Clinical Trial

Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX

Study acronym: T-REX
Recruiting
View on ClinicalTrials.gov →
Summary
The study is a pre-implementation cross-sectional study exploring chemsex behaviors among transgender persons and gathering perspectives from multiple stakeholders to inform the development of transgender-tailored harm reduction services.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-04-07
Trial Details
NCT Number NCT07505875
Lead Sponsor Institute of HIV Research and Innovation Foundation, Thailand
Collaborators: amfAR, The Foundation for AIDS Research
Conditions Substance Use, HIV Prevention, Sexually Transmitted Infections (STIs)
Enrollment 50 participants
Start Date 2024-05-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-06